bibliographic entry 11398857 [be/11398857]
https://w3id.org/oc/corpus/be/11398857

is a
content
  • Jordan J, Tank J, Heusser K et al. Empagliflozin (EMPA) has no discernable effect on muscle sympathetic nerve activity (MSNA) in patients with type 2 diabetes (T2DM) despite reductions in blood pressure (BP) and weight. Diabetes 2014; 63: A265 (Suppl. 1).
references